Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaP Rougier, A Adenis, M Ducreux, et al.
Bone Marrow Transplantation|January 16, 2013
KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantationA Garfall, H T Kim, L Sun, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)Charlotte van Kesteren, R A A Mathôt, E Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracilP Wibault, M A Bensmaine, M de Forni, et al.
British Journal of Cancer|September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckX Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndromeE D Jacobsen, H T Kim, V T Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
NMR determination of the major solution conformation of a peptoid pentamer with chiral side chainsP Armand, K Kirshenbaum, R A Goldsmith, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaP Rougier, A Adenis, M Ducreux, et al.
Bone Marrow Transplantation|January 16, 2013
KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantationA Garfall, H T Kim, L Sun, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)Charlotte van Kesteren, R A A Mathôt, E Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracilP Wibault, M A Bensmaine, M de Forni, et al.
British Journal of Cancer|September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckX Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndromeE D Jacobsen, H T Kim, V T Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsJ-C Soria, J Cortes, C Massard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
NMR determination of the major solution conformation of a peptoid pentamer with chiral side chainsP Armand, K Kirshenbaum, R A Goldsmith, et al.
Pageof 24